We are live on !
Find out more
Daniel Loeb Third Point
AUM
$4.68B
Turnover
50%
1-Year Est. Return
37.3%
Daniel Loeb is the founder of Third Point, an event-driven and activist-oriented hedge fund. He is known for pointed letters to management teams, catalyst-driven investing, and a flexible mandate across equities and credit. Loeb’s campaigns and portfolio shifts regularly generate attention beyond specialist hedge fund circles.
This Fund
S&P 500
This Quarter Est. Return
+14.26%
1 Year Est. Return
+37.3%
3 Year Est. Return
+159.49%
5 Year Est. Return
+329.12%
10 Year Est. Return
+1,791.94%
AUM
$5.97B
AUM Growth
+$433M
(+7.8%)
Cap. Flow
+$26.8M
Cap. Flow % of AUM
Cap. Flow %
0.45%
Top 10 Holdings %
Top 10 Hldgs %
80.33%
Holding
65
New
5
Increased
4
Reduced
4
Closed
21
Avg Time Held
1.4
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American International
AIG
|
+$297M |
| 2 |
Microsoft
MSFT
|
+$283M |
| 3 |
International Flavors & Fragrances
IFF
|
+$226M |
| 4 |
Bath & Body Works
BBWI
|
+$209M |
| 5 |
Fidelity National Information Services
FIS
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$241M |
| 2 |
EQT Corp
EQT
|
+$132M |
| 3 |
Range Resources
RRC
|
+$98.5M |
| 4 |
Ventyx Biosciences
VTYX
|
+$98.1M |
| 5 |
T-Mobile US
TMUS
|
+$93.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.27% |
| 2 | Utilities | 16.1% |
| 3 | Consumer Staples | 15.25% |
| 4 | Consumer Discretionary | 13.27% |
| 5 | Technology | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PG&E
PCG
$39.5B
| $960M | 16.1% |
59,070,000
-4,330,000
| -7% | -$65.5M |
2020 Q3
9 quarters
|
|
2
Colgate-Palmolive
CL
$74.5B
| $910M | 15.25% |
11,550,000
| – | – |
2022 Q2
2 quarters
|
|
3
Danaher
DHR
$164B
| $717M | 12.01% |
3,045,600
| – | – |
2015 Q3
29 quarters
|
|
|
4
Bath & Body Works
BBWI
$4.12B
| $579M | 9.71% |
13,750,000
+5,615,000
| +69% | +$209M |
2022 Q3
1 quarter
|
|
5
UnitedHealth
UNH
$374B
| $355M | 5.95% |
670,000
| – | – |
2020 Q4
8 quarters
|
|
|
6
American International
AIG
$42.7B
| $323M | 5.4% |
+5,100,000
| New | +$297M |
2022 Q4
0 quarters
|
|
|
7
Microsoft
MSFT
$3.96T
| $283M | 4.74% |
+1,180,000
| New | +$283M |
2022 Q4
0 quarters
|
|
|
8
International Flavors & Fragrances
IFF
$23.2B
| $241M | 4.04% |
+2,300,000
| New | +$226M |
2022 Q4
0 quarters
|
|
9
SentinelOne
S
$7.93B
| $214M | 3.59% |
14,700,000
-4,300,000
| -23% | -$79.6M |
2021 Q2
6 quarters
|
|
10
TJX Companies
TJX
$160B
| $211M | 3.53% |
2,650,000
+900,000
| +51% | +$66.5M |
2022 Q3
1 quarter
|
|
11
DuPont de Nemours
DD
$18.1B
| $206M | 3.45% |
2,390,000
+497,917
| +26% | +$39.8M |
2021 Q1
7 quarters
|
|
12
Ovintiv
OVV
$19.3B
| $203M | 3.4% |
4,000,000
| – | – |
2022 Q1
3 quarters
|
|
|
13
Fidelity National Information Services
FIS
$18.8B
| $136M | 2.27% |
+2,000,000
| New | +$142M |
2022 Q4
0 quarters
|
|
14
Ferguson
FERG
$44.1B
| $117M | 1.97% |
925,000
| – | – |
2022 Q3
1 quarter
|
|
15
Walt Disney
DIS
$193B
| $82.5M | 1.38% |
950,000
-450,000
| -32% | -$43M |
2022 Q2
2 quarters
|
|
16
Hertz
HTZ
$738M
| $82.3M | 1.38% |
5,350,000
| – | – |
2021 Q4
4 quarters
|
|
|
PCGU
17
DELISTED
PG&E Corporation
PCGU
| $67.9M | 1.14% |
471,000
| – | – |
2020 Q3
9 quarters
|
|
18
Labcorp
LH
$26.3B
| $45.2M | 0.76% |
+223,634
| New | +$43.7M |
2022 Q4
0 quarters
|
|
19
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
| $40.4M | 0.68% |
4,000,000
| – | – |
2021 Q2
6 quarters
|
|
20
DELISTED
Global Blue Group Holding
GB
| $39.5M | 0.66% |
8,537,601
| – | – |
2018 Q2
18 quarters
|
|
|
21
DELISTED
Ventyx Biosciences
VTYX
| $32.8M | 0.55% |
1,000,000
-3,312,834
| -77% | -$98.1M |
2021 Q4
4 quarters
|
|
|
KVSC
22
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
| $19.9M | 0.33% |
2,000,000
| – | – |
2021 Q1
7 quarters
|
|
|
BWC
23
DELISTED
Blue Whale Acquisition Corp I Class A Ordinary Shares
BWC
| $19.6M | 0.33% |
2,000,000
| – | – |
2021 Q4
4 quarters
|
|
24
NET Power
NPWR
$91.1M
| $15.3M | 0.26% |
1,500,000
| – | – |
2021 Q4
4 quarters
|
|
|
DGNU
25
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
| $11.8M | 0.2% |
1,200,000
| – | – |
2021 Q1
7 quarters
|
|
Similar funds
TCIM
Daniel Loeb's Q4 2022 Portfolio in Review
As of Q4 2022, Daniel Loeb held 65 positions worth $5.97B, up 7.8% from $5.53B the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Daniel Loeb's Q4 2022 filing shows 5 new, 4 increased, 4 reduced and 21 closed positions. Its largest new stake was American International: 5,100,000 shares worth $323M. The largest sale was Twitter, Inc., an estimated $241M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 23% a quarter earlier, followed by Utilities and Consumer Staples.
- Daniel Loeb's largest Q4 2022 buy was American International: 5,100,000 shares worth $323M.
- Daniel Loeb added most to Bath & Body Works in Q4 2022, an estimated $209M increase.
- Daniel Loeb's biggest Q4 2022 reduction was Ventyx Biosciences, cutting an estimated $98.1M.
- Daniel Loeb fully exited Twitter, Inc. in Q4 2022, selling an estimated $241M.
- Daniel Loeb's ten largest holdings make up 80% of its $5.97B portfolio in Q4 2022.
- Daniel Loeb opened 5 new positions and closed 21 in Q4 2022.
- Daniel Loeb's portfolio value rose 7.8% quarter-over-quarter to $5.97B.
Based on Third Point's 13F filing for Q4 2022, filed 14 Feb 2023.